ArticleMedicine2026
Association of inflammatory indices with coronary artery calcium burden in fibromyalgia: A retrospective CT-based cross-sectional study.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fibromyalgia (FM) may involve systemic abnormalities in addition to its characteristic nociplastic pain features. This study aimed to investigate the association between routinely available inflammatory indices, particularly the neutrophil-to-lymphocyte ratio (NLR), and coronary artery calcium (CAC) burden in patients with FM. A total of 142 patients with FM and 64 controls were included. Computed tomography-derived CAC scores were categorized as < 100 or ≥ 100, with CAC ≥ 400 examined as an exploratory threshold. Multiple inflammatory indices were evaluated, and multivariable logistic regression models included demographic and cardiovascular risk factors, with additional adjustment for low-density lipoprotein cholesterol and statin use. NLR differed across the 3 groups after Bonferroni correction for multiple testing; pairwise analysis showed a higher NLR in patients with FM and CAC ≥ 100 than in those with CAC < 100. Among the evaluated inflammatory indices, NLR showed the strongest correlation with CAC score (r = 0.371, Bonferroni-adjusted P < .001). After additional adjustment for diabetes mellitus, hypertension, low-density lipoprotein cholesterol, and statin use, NLR remained associated with CAC ≥ 100 (adjusted odds ratio 3.57, 95% confidence interval 1.15-11.07, P = .028) and CAC ≥ 400 (adjusted odds ratio 3.97, 95% confidence interval 1.14-13.81, P = .030). Receiver operating characteristic analyses showed limited-to-modest discriminatory performance of NLR for CAC ≥ 100 (area under the curve 0.67) and CAC ≥ 400 (area under the curve 0.69). This study identified an independent association between NLR and CAC burden in patients with FM, despite modest between-group differences and limited-to-modest discriminatory performance. These findings are hypothesis-generating and support prospective evaluation of NLR as part of multimarker cardiovascular assessment in FM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.